Six month operating loss increases slightly at Scancell

AIM-listed medical company Scancell has published its unaudited interim results for the six month period to October 31st, showing an overall operating loss of 989,981 pounds.

AIM-listed medical company Scancell has published its unaudited interim results for the six month period to October 31st, showing an overall operating loss of 989,981 pounds.

This compared to a loss of £941,674 in the corresponding period in 2011.

The cash at bank on October 31st was £2.6m compared to £3.3m on April 30th.

In spite of the slight increase in operating loss, the group reported encouraging preliminary results from the Part 1 of the Phase 1/2clinical trial for its SCIB1 melanoma vaccine and the receipt of an approval to dose an extra group of patients with a higher, 8.0mg, dose of the vaccine.

David Evans, Chairman of Scancell, commented: "During 2013, the assessment of a higher dose in patients with evaluable disease and the future assessment of immune response in part two of the clinical trials should provide further evidence to support the use of ImmunoBody vaccines for the treatment of cancers."

He added: "Whilst at an early stage with the new Moditope technology platform, the board is aware that the opportunities could be considerable and, with its existing ImmunoBody technology is confident that the company is well placed to create increasing value for shareholders."

Scancell's share price was down 2.86% to 38.25p at 14:20 on Thursday.

MF

Recommended

Broker safety – your questions answered
Investment strategy

Broker safety – your questions answered

Cris Sholto Heaton answers more of your questions about the safety of stockbroker accounts
25 Mar 2020
How demographics affects stock valuations
Investment strategy

How demographics affects stock valuations

New research suggests that stock and bond valuations are driven by the age of the population – at least in the US.
24 Feb 2020
Do you own shares in Sirius Minerals? Here’s what you need to do now
Stocks and shares

Do you own shares in Sirius Minerals? Here’s what you need to do now

Mining giant Anglo American has proposed a cash takeover of Yorkshire-based minnow Sirius Minerals. Unhappy shareholders must decide whether to accept…
20 Feb 2020

Most Popular

Why we won’t see a house-price crash in 2021
House prices

Why we won’t see a house-price crash in 2021

Lockdown sent house prices berserk as cooped up home-workers fled for bigger properties in the country. And while they won’t rise quite as much this y…
18 Jan 2021
Inflation is the easiest way out of this – just don’t expect politicians to admit it
Inflation

Inflation is the easiest way out of this – just don’t expect politicians to admit it

The UK government borrowed £34.1bn in December, a record amount for that month. Britain's debt pile now amounts to 100% of GDP. How are we going to pa…
22 Jan 2021
When will the US stockmarket bubble burst?
US stockmarkets

When will the US stockmarket bubble burst?

With US stocks more expensive than before the Wall Street crash of 1929, there are growing signs of “mania”. But what will push markets over the edge?
22 Jan 2021